Peer-reviewed veterinary case report
Tailoring the active phase of CoO-based thin-film catalysts in order to tune selectivity in CO<sub>2</sub> hydrogenation.
- Year:
- 2024
- Authors:
- Mohammadpour N et al.
- Affiliation:
- Department of Molecular Engineering
Abstract
In this study, we prepared CoO-based thin films deposited on Kanthal steel wire gauze meshes by plasma-enhanced chemical vapor deposition. X-ray photoelectron spectroscopy (XPS) analysis revealed a structure characterized by a combination of cobalt oxide and metallic cobalt embedded within a carbon matrix. Our primary objective was to gain insights into the roles of Co<sup>0</sup> and CoO in CO<sub>2</sub> hydrogenation reactions. To achieve this, the performance of the thin-film CoO-based catalyst with an initial atomic ratio of CoO/Co<sup>0</sup> at 10.2 was compared with two series of the thin-film catalysts that underwent pre-reduction processes at 350 °C for durations of 30 and 60 minutes, resulting in atomic ratios of CoO/Co<sup>0</sup> at 3.1 and 1.1, respectively. Subsequently, catalytic tests were conducted in a continuous flow stirred tank reactor operating at temperatures ranging from 250 °C to 400 °C. Our findings indicate that CoO plays a significant role in activating the CO<sub>2</sub> methanation reaction which can be due to the high hydrogen coverage of CoO, while Co<sup>0</sup> is the active phase in the reverse water-gas shift reaction. Results highlight the importance of oxidized cobalt for hydrogen adsorption and dissociation in CO<sub>2</sub> hydrogenation for CH<sub>4</sub> formation.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://europepmc.org/article/MED/38784413